Travere Therapeutics, Inc.

SEC 4 · Filed

0001477384-26-000008Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date May 19, 2026

Grant, award or other acquisition by Orwin John A

Security
Stock option (right to buy)
Code
A
Shares
12,000
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-05-19",
  "direction": "A",
  "exercise_price": "42.26",
  "expiration": "2036-05-19",
  "footnotes": {
    "F1": "Automatic equity grant under the Issuer\u0027s 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program.",
    "F2": "The equity award vests over a one year period."
  },
  "owners": [
    {
      "cik": "0001477384",
      "name": "Orwin John A",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "12000",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Stock option (right to buy)",
  "shares": "12000",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "12000"
}
Insider transactionsEvent date May 19, 2026

Grant, award or other acquisition by Orwin John A

Security
Common Stock
Code
A
Shares
4,000
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-05-19",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Automatic equity grant under the Issuer\u0027s 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program.",
    "F2": "The equity award vests over a one year period."
  },
  "owners": [
    {
      "cik": "0001477384",
      "name": "Orwin John A",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "39375",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Common Stock",
  "shares": "4000",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}